Shamrock Industrial Company Ltd (531240) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531240 | NSE: | Pharmaceuticals & Drugs | Small Cap

Shamrock Indl. Co Share Price

18.48 0.00 0.00%
as on 01-Dec'25 16:59

Shamrock Industrial Company Ltd (531240) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531240 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Shamrock Indl. Co

Based on:

M-Cap below 100cr DeciZen not available

Shamrock Industrial Company stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
10 Cr.
52-wk low:
10.8
52-wk high:
18.5

Is Shamrock Industrial Company Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Shamrock Indl. Co: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Shamrock Industrial Company Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -21.9%-0.7%-0.9%-5.7%-8.7%-13.9%-10.4%-7%-2.3%-7.6%-
Value Creation
Index
-2.6-1.1-1.1-1.4-1.6-2.0-1.7-1.5-1.2-1.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS -3.8-0.1-0.1-8.9-0.4-0.6-0.4-0.2-0.1-0.2-0.9
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 5.65.55.44.94.53.93.53.33.232.2
Adj Net
Profit
-2-0.1-0.1-4.8-0.2-0.3-0.2-0.1-0-0.1-0
Cash Flow from Ops. -1.900-8.6-0.6-0.3-0.3-0-0-0.1-
Debt/CF from Ops. -2.449342705.20000000-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPS-6.9%-7.9%-5.4%-7.2%
Share Price 18.3% 40% 42.4% 58%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-105.5-1.9-2.2-172.6-8.7-13.9-10.4-7-2.3-7.6-34.8
Op. Profit
Mgn %
0000000000NAN
Net Profit
Mgn %
0000000000-INF
Debt to
Equity
1.51.51.600000000
Working Cap
Days
00000000000
Cash Conv.
Cycle
00000000000

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Shamrock Industrial Company Ltd.

Standalone Consolidated
TTM EPS (₹) -0.9 -
TTM Sales (₹ Cr.) 0 -
BVPS (₹.) 2.2 -
Reserves (₹ Cr.) -4 -
P/BV 8.57 -
PE 0.00 -
From the Market
52 Week Low / High (₹) 10.76 / 18.48
All Time Low / High (₹) 0.25 / 24.00
Market Cap (₹ Cr.) 10
Equity (₹ Cr.) 5.4
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Shamrock Indl. Co:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Shamrock Indl. Co - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Shamrock Indl. Co

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales0000000000
Operating Expenses 3.430.060.103.660.220.320.300.130.150.13
Manufacturing Costs0000000000
Material Costs0000000000
Employee Cost 000.020.140.040.010.020.020.020.02
Other Costs 3.430.050.083.510.180.320.280.110.130.11
Operating Profit -3.43-0.06-0.10-3.66-0.22-0.32-0.30-0.13-0.15-0.13
Operating Profit Margin (%) ----------
Other Income 1.5400.03000.010.1000.110
Interest 0.16000000000
Depreciation 0000000000
Exceptional Items 0003.37000000
Profit Before Tax -2.04-0.06-0.06-0.29-0.22-0.31-0.21-0.13-0.04-0.13
Tax 0000000000
Profit After Tax -2.04-0.06-0.06-0.29-0.22-0.31-0.21-0.13-0.04-0.13
PAT Margin (%) ----------
Adjusted EPS (₹)-3.8-0.1-0.1-0.5-0.4-0.6-0.4-0.2-0.1-0.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 3.052.992.932.642.422.111.901.771.731.60
Share Capital 5.435.435.435.435.435.435.435.435.435.43
Reserves -2.38-2.44-2.50-2.79-3.01-3.32-3.53-3.66-3.70-3.82
Minority Interest0000000000
Debt4.514.544.610000000
Long Term Debt0000000000
Short Term Debt4.514.544.610000000
Trade Payables0.050.060.100.040.040.050.040.030.030.03
Others Liabilities 0.040.04-00.3400.01-0-0-00
Total Liabilities 7.647.637.633.022.462.161.941.801.761.64

Fixed Assets

Gross Block1.191.191.190.140.140.140.140.140.140.14
Accumulated Depreciation0.140.140.140.140.140.140.140.140.140.14
Net Fixed Assets 1.051.051.050000000
CWIP 3.423.423.420000000
Investments 3.093.093.090000000
Inventories0000000000
Trade Receivables0000000.11000
Cash Equivalents 0.010.010.012.221.661.3410.970.930.01
Others Assets 0.080.060.060.800.800.820.830.830.831.62
Total Assets 7.647.637.633.022.462.161.941.801.761.64

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity -1.9200-8.61-0.56-0.31-0.34-0.04-0.04-0.13
PBT -2.04-0.06-0.06-0.29-0.22-0.31-0.21-0.13-0.04-0.13
Adjustment 000-3.37000000
Changes in Working Capital -4.150.060.07-4.95-0.34-0-0.130.090-0
Tax Paid 0000000-000
Cash Flow From Investing Activity 1.910-010.8200000-0.79
Capex 00-010.93000000
Net Investments 0000000000
Others 1.9100-0.1100000-0.79
Cash Flow From Financing Activity 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow -0.010-02.21-0.56-0.31-0.34-0.04-0.04-0.92

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-105.51-1.85-2.17-10.35-8.68-13.86-10.35-7-2.32-7.56
ROCE (%)-21.87-0.74-0.85-5.66-8.68-13.86-10.35-6.96-2.32-7.56
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days0000000000

Shamrock Industrial Company Ltd Stock News

Shamrock Industrial Company Ltd FAQs

The current trading price of Shamrock Indl. Co on 01-Dec-2025 16:59 is ₹18.48.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 30-Nov-2025 the market cap of Shamrock Indl. Co stood at ₹10.03.
The latest P/E ratio of Shamrock Indl. Co as of 30-Nov-2025 is 0.00.
The latest P/B ratio of Shamrock Indl. Co as of 30-Nov-2025 is 8.57.
The 52-week high of Shamrock Indl. Co is ₹18.48 and the 52-week low is ₹10.76.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Shamrock Indl. Co is ₹0.00 ( Cr.) .

About Shamrock Industrial Company Ltd

Shamrock Industrial Company (SICL) is the manufacturing division of Shamrock Group of Companies, who have been primarily involved in the field of Pharmaceutical Raw Materials, Intermediates and Fine Chemicals since the past 23 years.

The company has 4 manufacturing facilities strategically located at Taloja, Chennai and Baroda in India, where they are producing high quality products and exporting them to more than 35 countries worldwide. In fact, 100% of their sales comprise of exports to the overseas markets catering solely to the Pharmaceutical.

Today Shamrock is a 100% export oriented company with several satisfied and esteemed customers which include some of the leading API manufacturers, multinational companies, leading laboratories and pharmaceutical companies in more than 40 countries worldwide.

Their manufacturing locations are as per GMP standards and are obtaining ISO 9000 and ISO 14000 certification. The Khopoli unit is designed to meet with U.S. FDA standards. The units are so designed that they have dedicated plants as well as multi purpose plants catering to custom manufacturing activities and which have enough capacity to manufacture a very wide range of products. The equipments are specially designed so as to execute various processes and reactions including Multi Stage Process.

The facilities of the company are capable of handling several hazardous reactions like cynation, nitration, bromination, high pressure and temperature conditions,catalytic hydrogenation, etc. Reactions handled are from – 40 °C to 200 °C and Pressures – handled up to 15 ATM.  They have a total reactive volume of about 250000 ltrs (250m3). The Manufacturing Equipment list and Reaction Capabilities list is separately enclosed.

Their production facilities also include Pilot Plant where several reactions are taken up on trial basis ranging from 10 kgs to 100 kgs. In fact, on an average, they scale up approximately 20 – 30 new products every year on the Pilot Plant and subsequently the commercial production begins.

Besides this, they also use Pilot Plants for constant improvisation of a particular process and to carry out various trials for the purpose of “Adding Value to Basic Chemistry”.

Their production facilities undergo constant updating so as to fulfill the manufacturing quality standards of the FDA. Their facilities have also been approved by many of their customers including multinational companies. Their endeavour and focus has been in the BASIC BACKWARD INTEGRATION by producing the intermediates or raw materials from the basic stage.

Product range of the company includes:

Shamrock is a 100% export oriented company with several satisfied and esteemed customers which include some of the leading API manufacturers, multinational companies, leading laboratries and pharmaceutical companies in more than 40 countries worldwide.

  • Basic Chemicals
  • Fine Chemicals
  • Intermediates
  • Advanced Intermediates
  • APIs.

Achievements/ recognition:

  • The Khopoli unit of the company is designed to meet with U.S. FDA standards.
  • Their manufacturing locations are as per GMP Standards
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×